−0.012 AUD
−3.58 M AUD
0.00 AUD
283.20 M
About NOXOPHARM LIMITED
Sector
CEO
Gisela Mautner
Headquarters
Chatswood
Website
Founded
2015
ISIN
AU000000NOX9
FIGI
BBG00D34SWS8
Noxopharm Ltd. engages in the research and development of drugs. It focuses on sensitizing cancer cells to radiotherapy and chemotherapy. The company was founded by Graham Kelly on October 27, 2015 and is headquartered in Chatswood, Australia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NOX is 0.095 AUD — it has increased by 2.15% in the past 24 hours. Watch NOXOPHARM LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange NOXOPHARM LIMITED stocks are traded under the ticker NOX.
NOX stock has fallen by −5.00% compared to the previous week, the month change is a −9.52% fall, over the last year NOXOPHARM LIMITED has showed a 35.71% increase.
NOX stock is 3.26% volatile and has beta coefficient of −0.83. Track NOXOPHARM LIMITED stock price on the chart and check out the list of the most volatile stocks — is NOXOPHARM LIMITED there?
Yes, you can track NOXOPHARM LIMITED financials in yearly and quarterly reports right on TradingView.
NOX net income for the last half-year is −1.08 M AUD, while the previous report showed −2.50 M AUD of net income which accounts for 56.76% change. Track more NOXOPHARM LIMITED financial stats to get the full picture.
No, NOX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NOX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOXOPHARM LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOXOPHARM LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOXOPHARM LIMITED stock shows the sell signal. See more of NOXOPHARM LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.